Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

Disclosure: The author holds a long position in AMPX.

← Back to Free Index

AMPX

Analysis as of: 2026-05-07

Amprius Technologies, Inc.

Amprius develops and sells high-energy silicon-anode lithium-ion battery cells for drones, defense, aerospace and select electric mobility applications.

aerospace defense energy robotics transportation

On Yahoo Finance ...

Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

Battery Edge Is Real, Scale Proof Matters

The business has moved beyond pure concept risk: demand, margins and domestic supply progress are visible. The harder question now is whether outsourced scale and repeat orders arrive fast enough to justify a still-rich valuation.

Analysis

Thesis

Amprius can turn a real performance lead in silicon-anode batteries into a scaled, capital-light niche franchise for drones, defense, aerospace and select mobility, but the stock outcome now hinges on proving repeat orders, partner yields and supply control faster than valuation compresses.

Last Economy Alignment

AI expands demand for longer-endurance drones, robotics and defense systems, and Amprius owns real chemistry, qualification and trusted-supply control points; it benefits from the Last Economy rather than being commoditized by it.

Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple

2.0x (from 5 most recent analyses)

Reasoning

Revenue can compound quickly as drone, defense and mobility programs move from qualification into repeat orders, module content lifts dollar capture, and partner capacity enables scale without a gigafactory balance sheet. But the equity likely grows slower than revenue because today’s scarcity multiple should compress as execution proof replaces optionality.

Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary

The main risk is execution, not science. Amprius must convert superior cells into repeat program revenue while preserving quality, yields and premium pricing through outside manufacturers and a concentrated material chain. If qualification cycles slip, defense sourcing shifts, or competing chemistries narrow the performance gap, today’s valuation leaves little room for disappointment.

Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Trends

Key Changes

May 6, 2026: Q1 revenue reached 28.5 and gross margin reached 20%, while 2026 revenue guidance was raised to at least 130.
May 7, 2026: the company announced an exchange for 7.13 million public warrants, expected to close on May 18, which should reduce overhang and simplify the capital structure.
May 1, 2026: management highlighted NDAA-compliant drone energy solutions in its event schedule, reinforcing defense as a near-term demand driver.

Thesis update

The core thesis is intact, but recent disclosures improved confidence that demand is real and shifted the debate further toward delivery, repeat orders and margin durability.

Forecast update

Improved shipment visibility, better margin evidence, domestic manufacturing optionality and capital-structure cleanup modestly improved the risk-adjusted equity path.

Upgrade to Builder to also access: Future Considerations

Last Economy Structure

AI Industrial Score

0.47

They sell a physical bottleneck that AI-era drones and defense systems need: lighter batteries with trusted supply. The upside comes from longer-flight performance and compliance, but the risk is that bigger battery makers catch up or outside partners become the real choke point.

Upgrade to Reader to also access: Score Decomposition, Confidence Level

Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility

Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target

$19.75

Upgrade to Reader to also access: Bull Case, Base Case, Bear Case

Next Arc Research